Skip to main content
. 2021 Jul 10;28(10):5507–5512. doi: 10.1245/s10434-021-10446-8

Table 1.

Patient and perioperative treatment characteristics by study period

Variable Opioid period (n = 858) NSAID period (n = 1866) P
Age at surgery, yr 59 (50–67) 59 (51–67) 0.9
BMI, kg/m2 27.1 (23.4–31.9) 27.3 (23.8–32.1) 0.2
Race/ethnicity 0.03
 White 616 (72) 1182 (63)
 Black/African American 59 (6.9) 168 (9.0)
 Hispanic/Latino 64 (7.5) 142 (7.6)
 Asian/Pacific Islander 73 (8.5) 180 (9.6)
 Unknown 46 194
ASA class 0.4
 1 10 (1.2) 26 (1.4)
 2 558 (65) 1148 (62)
 3 289 (34) 690 (37)
 4 1 (0.1) 2 (0.1)
Home medications
 Aspirin 108 (13) 206 (11) 0.2
 Anticoagulant or other antiplatelet 22 (2.6) 56 (3.0) 0.6
 Intraoperative ketorolac 549 (64) 1463 (78) < 0.001
 Intraoperative acetaminophen 830 (97) 1823 (98) 0.2
 Intraoperative opioids, MME 20 (10–20) 20 (10–20) 0.7

Data are expressed as medians with interquartile range in parentheses or numbers with percentages in parentheses unless otherwise indicated

ASA American Society of Anesthesiologists; BMI body mass index; MME morphine milligram equivalent; NSAID nonsteroidal anti-inflammatory drug

HHS Vulnerability Disclosure